Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.
Stroke
HRS2014: Devices combat drugs for treatment of AF stroke-risk patients
New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.
Study: AliveCor’s mobile ECG helps discover hidden stroke risk
Smartphone-based community ECG readings may help save lives as well as healthcare dollars, according to a study unveiled by mobile health company AliveCor.